New cell therapy for MS enters human safety testing
NCT ID NCT07008378
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 29 times
Summary
This early-stage study tests an experimental treatment called P-CD19CD20-ALLO1 in 60 adults with multiple sclerosis. The main goal is to check if it is safe and how the body handles it. Researchers will also measure how long the treatment lasts in the blood and how it affects immune cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Multiple Sclerosis Comprehensive Care Center at Northwell Health
New York, New York, 10075, United States
-
Rutgers University- Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901-1962, United States
-
UCI Sue & Bill Gross Stem Cell Research Center
Irvine, California, 92697, United States
-
UCSD Altman Clinical and Translational Research Institute
La Jolla, California, 92037-1337, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110-1010, United States
Conditions
Explore the condition pages connected to this study.